I agree that this site is using cookies. You can find further informations here.
X
García-Moure, M
~ 500  results:
Search for persons X
?
1

P17.14.B PHASE I TRIAL OF DNX-2401 ONCOLYTIC ADENOVIRUS COM..:

Gallego Perez-Larraya, J ; García-Moure, M ; González-Huárriz, M...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii120-ii120 , 2023
Link: https://doi.org/10.1093/..
 
?
2

P17.15.A THANK PHASE I TRIAL OF DNX-2440 ONCOLYTIC ADENOVIR..:

Gallego Perez-Larraya, J ; de la Nava, D ; González-Huárriz, M...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii120-ii120 , 2023
Link: https://doi.org/10.1093/..
 
?
3

P06.01 Delta24-ACT oncolytic adenovirus as a therapeutic ap..:

Laspidea, V ; Puigdelloses, M ; García-Moure, M...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii36-iii36 , 2019
Link: https://doi.org/10.1093/..
 
?
4

P11.56 Oncolytic virus and tumor microenvironment modulator..:

Puigdelloses, M ; Martinez-Velez, N ; García-Moure, M...
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii56-iii56 , 2019
Link: https://doi.org/10.1093/..
 
?
5

P11.23 Oncolytic adenovirus Delta-24-RGD exerts a potent an..:

Garcia Moure, M ; González Huarriz, M ; Marrodán, L..
Neuro-Oncology.  21 (2019)  Supplement_3 - p. iii47-iii47 , 2019
Link: https://doi.org/10.1093/..
 
?
6

The oncolytic virus Delta-24-RGD elicits an antitumor effec..:

Martínez-Vélez, N ; Garcia-Moure, M ; Marigil, M...
Nature communications, 2019, 10 (1), pp. 2235 - ?.  , 2019
Link: https://repository.icr.a..
 
?
7

CD137 and PD-L1 targeting with immunovirotherapy induces a ..:

Puigdelloses-Vallcorba, M. (Montserrat) ; Garcia-Moure, M. (Marc) ; Labiano, S. (Sara)...
10.1136 / jitc-2021-002644.  , 2021
Link: https://hdl.handle.net/1..
 
?
8

Viroinmunoterapia para el tumor rabdoide/ teratoide atípico..:

Gonzalez-Huarriz, M. (Marisol) ; Alonso-Roldán, M.M. (Marta María) ; Garcia-Moure, M. (Marc)
https://hdl.handle.net/10171/61096.  , 2021
Link: https://hdl.handle.net/1..
 
?
9

RNU6-1 in circulating exosomes differentiates GBM from non-..:

Puigdelloses-Vallcorba, M. (Montserrat) ; Gonzalez-Huarriz, M. (Marisol) ; Garcia-Moure, M. (Marc)...
info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI19%2F01440/ES/PAPEL DEL RNU6 AISLADO DE EXOSOMAS CIRCULANTES COMO MARCADOR DIAGNOSTICO Y DE SEGUIMIENTO EN PACIENTES CON GLIOBLASTOMA.  , 2020
Link: https://hdl.handle.net/1..
 
?
10

The oncolytic virus Delta-24-RGD elicits an antitumor effec..:

Martinez-Velez, N. (Naiara) ; Garcia-Moure, M. (Marc) ; Marigil, M. (Miguel)...
info:eu-repo/grantAgreement/EC/H2020/817884/EU.  , 2019
Link: https://hdl.handle.net/1..
 
?
11

The oncolytic adenovirus VCN01 promotes anti tumor effect i..:

Garcia-Moure, M. (Marc) ; Martinez-Velez, N. (Naiara) ; Gonzalez-Huarriz, M. (Marisol)...
info:eu-repo/grantAgreement/EC/H2020/817884/EU.  , 2019
Link: https://hdl.handle.net/1..
 
?
12

Delta-24-RGD combined with radiotherapy exerts a potent ant..:

Martinez-Velez, N. (Naiara) ; Marigil, M. (Miguel) ; Garcia-Moure, M. (Marc)...
info:eu-repo/grantAgreement/EC/H2020/817884/EU.  , 2019
Link: https://hdl.handle.net/1..
 
?
13

Oncolytic viruses as therapeutic tools for pediatric brain ..:

Varela-Guruceaga, M. (Maider) ; Tejada-Solis, S. (Sonia) ; Garcia-Moure, M. (Marc)...
https://hdl.handle.net/10171/64488.  , 2018
Link: https://hdl.handle.net/1..
 
?
14

Development of a DIPG Orthotopic Model in Mice Using an Imp..:

Marigil, M. (Miguel) ; Martinez-Velez, N. (Naiara) ; Domínguez-Echávarri, P.D. (Pablo Daniel)...
info:eu-repo/grantAgreement/MINECO/Ayudas para incentivar la incorporación estable de doctores (2015)/IEDI- 2015-00638/ES/IEDI-2015-00638.  , 2017
Link: https://hdl.handle.net/1..
 
?
15

DIPG-45. TARGETING HYPERACETYLATION IN PEDIATRIC DIFFUSE MI..:

Parthasarathy, Akhila ; Garcia-Moure, Marc ; He, Jiasen...
Neuro-Oncology.  26 (2024)  Supplement_4 - p. 0-0 , 2024
Link: https://doi.org/10.1093/..
 
1-15